Quent Capital’s Calithera Biosciences, Inc CALA Stock Holding History

Quent Capital’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2	Closed	–	–	1364
2023 Q1	$0	Hold	2	–	–	﹤0.01%	1358
2022 Q4	$7	Hold	2	–	–	﹤0.01%	1316
2022 Q3	$0	Hold	2	–	–	﹤0.01%	1307
2022 Q2	$0	Sell	2 -1	-33%	-$5	﹤0.01%	1366
2022 Q1	$0	Hold	3	–	–	﹤0.01%	1343
2021 Q4	$0	Buy	+3	New	+$75	﹤0.01%	1083

Other funds holding CALA

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Quent Capital's CALA Position: Q2 2023 in Review

Quent Capital sold out of Calithera Biosciences, Inc (CALA) in Q2 2023, closing a stake of 2 shares.

Quent Capital first reported a position in CALA in Q4 2021 and held it in 6 quarters. The position peaked at $7 in Q4 2022. 1 fund tracked by Wall St. Rank holds CALA as of Q2 2023.

Quent Capital reported no remaining Calithera Biosciences, Inc position as of Q2 2023 after selling out during the quarter.
Quent Capital sold 2 Calithera Biosciences, Inc shares in Q2 2023.
Quent Capital first reported a position in Calithera Biosciences, Inc in Q4 2021 and held it in 6 quarters.
Quent Capital's Calithera Biosciences, Inc position peaked at $7 in Q4 2022.
1 fund tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2023.

Based on Quent Capital's 13F filing for Q2 2023, filed 10 Jul 2023.